Your browser doesn't support javascript.
loading
Infantile fibrosarcoma with TPM3-NTRK1 fusion in a boy with Bloom syndrome.
Huson, Sue M; Staab, Timo; Pereira, Marta; Ward, Heather; Paredes, Roberto; Evans, D Gareth; Baumhoer, Daniel; O'Sullivan, James; Cheesman, Ed; Schindler, Detlev; Meyer, Stefan.
Afiliación
  • Huson SM; Department of Genetic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, UK.
  • Staab T; Department of Human Genetics, University of Würzburg, Würzburg, Germany.
  • Pereira M; Department of Genetic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, UK.
  • Ward H; Department of Genetic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, UK.
  • Paredes R; Stem Cell and Leukaemia Proteomics Laboratory, School of Cancer and Imaging Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Evans DG; Department of Genetic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, UK.
  • Baumhoer D; Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • O'Sullivan J; Department of Genetic Medicine, St Mary's Hospital, Central Manchester Foundation Trust, Manchester, UK.
  • Cheesman E; Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Central Manchester Foundation Trust, Manchester, UK.
  • Schindler D; Department of Human Genetics, University of Würzburg, Würzburg, Germany.
  • Meyer S; Stem Cell and Leukaemia Proteomics Laboratory, School of Cancer and Imaging Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. stefan.meyer@manchester.ac.uk.
Fam Cancer ; 21(1): 85-90, 2022 01.
Article en En | MEDLINE | ID: mdl-33219493
ABSTRACT
Bloom syndrome (BS) is a genomic and chromosomal instability disorder with prodigious cancer predisposition caused by pathogenic variants in BLM. We report the clinical and genetic details of a boy who first presented with infantile fibrosarcoma (IFS) at the age of 6 months and subsequently was diagnosed with BS at the age of 9 years. Molecular analysis identified the pathogenic germline BLM sequence variants (c.1642C>T and c.2207_2212delinsTAGATTC). This is the first report of IFS related to BS, for which we show that both BLM alleles are maintained in the tumor and demonstrate a TPM3-NTKR1 fusion transcript in the IFS. Our communication emphasizes the importance of long-term follow up after treatment for pediatric neoplastic conditions, as clues to important genetic entities might manifest later, and the identification of a heritable tumor predisposition often leads to changes in patient surveillance and management.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Bloom / Fibrosarcoma Límite: Child / Humans / Infant / Male Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Bloom / Fibrosarcoma Límite: Child / Humans / Infant / Male Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido